Latest Bain Capital Life Sciences Investors, LLC Stock Portfolio
$1.04Billion
Equity Portfolio Value
Last Reported on: 13 Feb, 2024
About Bain Capital Life Sciences Investors, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Bain Capital Life Sciences Investors, LLC reported an equity portfolio of $1 Billions as of 31 Dec, 2023.
The top stock holdings of Bain Capital Life Sciences Investors, LLC are NUVL, NAMS, PHVS. The fund has invested 25.2% of it's portfolio in NUVALENT INC and 11.2% of portfolio in NEWAMSTERDAM PHARMA COMPANY.
The fund managers got completely rid off SPRINGWORKS THERAPEUTICS INC (SWTX), CRINETICS PHARMACEUTICALS IN (CRNX) and EQRX INC (EQRX) stocks. They significantly reduced their stock positions in NATERA INC (NTRA), PHARVARIS N V (PHVS) and 2SEVENTY BIO INC (TSVT). Bain Capital Life Sciences Investors, LLC opened new stock positions in MADRIGAL PHARMACEUTICALS INC (MDGL) and REVOLUTION MEDICINES INC (RVMD). The fund showed a lot of confidence in some stocks as they added substantially to ANNEXON INC (ANNX), SYROS PHARMACEUTICALS INC (SYRS) and X4 PHARMACEUTICALS INC (XFOR).
The top stock holdings of Bain Capital Life Sciences Investors, LLC are NUVL, NAMS, PHVS. The fund has invested 25.2% of it's portfolio in NUVALENT INC and 11.2% of portfolio in NEWAMSTERDAM PHARMA COMPANY.
The fund managers got completely rid off SPRINGWORKS THERAPEUTICS INC (SWTX), CRINETICS PHARMACEUTICALS IN (CRNX) and EQRX INC (EQRX) stocks. They significantly reduced their stock positions in NATERA INC (NTRA), PHARVARIS N V (PHVS) and 2SEVENTY BIO INC (TSVT). Bain Capital Life Sciences Investors, LLC opened new stock positions in MADRIGAL PHARMACEUTICALS INC (MDGL) and REVOLUTION MEDICINES INC (RVMD). The fund showed a lot of confidence in some stocks as they added substantially to ANNEXON INC (ANNX), SYROS PHARMACEUTICALS INC (SYRS) and X4 PHARMACEUTICALS INC (XFOR).
New Buys
| Ticker | $ Bought |
|---|---|
| MADRIGAL PHARMACEUTICALS INC | 75,110,300 |
| REVOLUTION MEDICINES INC | 31,903,500 |
New stocks bought by Bain Capital Life Sciences Investors, LLC
Additions
| Ticker | % Inc. |
|---|---|
| ANNEXON INC | 41.39 |
| SYROS PHARMACEUTICALS INC | 29.42 |
| X4 PHARMACEUTICALS INC | 5.98 |
| ACLARIS THERAPEUTICS INC | 2.94 |
Additions to existing portfolio by Bain Capital Life Sciences Investors, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| NATERA INC | -42.85 |
| PHARVARIS N V | -18.4 |
| 2SEVENTY BIO INC | -5.47 |
Bain Capital Life Sciences Investors, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| EQRX INC | -22,207,900 |
| SPRINGWORKS THERAPEUTICS INC | -71,239,800 |
| CRINETICS PHARMACEUTICALS IN | -37,934,900 |
| DYNAVAX TECHNOLOGIES CORP | -13,514,600 |
| CYMABAY THERAPEUTICS INC | -13,627,300 |
| CARA THERAPEUTICS INC | -39,725 |
Bain Capital Life Sciences Investors, LLC got rid off the above stocks
Current Stock Holdings of Bain Capital Life Sciences Investors, LLC
Last Reported on: 13 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ACRS | ACLARIS THERAPEUTICS INC | 0.35 | 3,500,000 | 3,675,000 | ADDED | 2.94 | |
| ADGI | INVIVYD INC | 0.73 | 1,937,210 | 7,632,600 | UNCHANGED | 0.00 | |
| ANNX | ANNEXON INC | 3.51 | 8,061,720 | 36,600,200 | ADDED | 41.39 | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 0.93 | 3,000,000 | 9,690,000 | UNCHANGED | 0.00 | |
| AVIR | ATEA PHARMACEUTICALS INC | 0.73 | 2,485,640 | 7,581,200 | UNCHANGED | 0.00 | |
| CABA | CABALETTA BIO INC | 4.35 | 2,000,000 | 45,400,000 | UNCHANGED | 0.00 | |
| CARA | CARA THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CBAY | CYMABAY THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CCCC | C4 THERAPEUTICS INC | 0.89 | 1,642,210 | 9,278,490 | UNCHANGED | 0.00 | |
| CRNX | CRINETICS PHARMACEUTICALS IN | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| EQRX | EQRX INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 7.20 | 324,619 | 75,110,300 | NEW | ||
| MRNS | MARINUS PHARMACEUTICALS INC | 1.49 | 1,431,060 | 15,555,600 | UNCHANGED | 0.00 | |
| MRSN | MERSANA THERAPEUTICS INC | 1.93 | 8,663,670 | 20,099,700 | UNCHANGED | 0.00 | |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 11.21 | 10,473,900 | 116,994,000 | UNCHANGED | 0.00 | |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 0.03 | 100,000 | 313,000 | UNCHANGED | 0.00 | |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 0.57 | 2,000,000 | 5,980,000 | UNCHANGED | 0.00 | |
| NRIX | NURIX THERAPEUTICS INC | 1.80 | 1,822,880 | 18,812,200 | UNCHANGED | 0.00 | |
| NTRA | NATERA INC | 2.40 | 400,197 | 25,068,300 | REDUCED | -42.85 | |
| NUVL | NUVALENT INC | 25.23 | 3,577,270 | 263,251,000 | UNCHANGED | 0.00 | |
| PHVS | PHARVARIS N V | 10.50 | 3,904,320 | 109,516,000 | REDUCED | -18.4 | |
| RPID | RAPID MICRO BIOSYSTEMS INC | 0.60 | 8,434,560 | 6,241,570 | UNCHANGED | 0.00 | |
| RVMD | REVOLUTION MEDICINES INC | 3.06 | 1,112,400 | 31,903,500 | NEW | ||
| SLDB | SOLID BIOSCIENCES INC | 1.84 | 3,130,420 | 19,220,800 | UNCHANGED | 0.00 | |
| SVRA | SAVARA INC | 6.41 | 14,232,800 | 66,893,900 | UNCHANGED | 0.00 | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| SYRS | SYROS PHARMACEUTICALS INC | 2.05 | 2,749,810 | 21,421,000 | ADDED | 29.42 | |
| TNGX | TANGO THERAPEUTICS INC | 2.74 | 2,892,660 | 28,637,400 | UNCHANGED | 0.00 | |
| TSVT | 2SEVENTY BIO INC | 0.54 | 1,331,800 | 5,686,790 | REDUCED | -5.47 | |
| XFOR | X4 PHARMACEUTICALS INC | 1.36 | 16,915,800 | 14,183,900 | ADDED | 5.98 | |
| XLO | XILIO THERAPEUTICS INC | 0.15 | 2,805,410 | 1,542,980 | UNCHANGED | 0.00 | |
| DISC MEDICINE INC | 7.38 | 1,332,540 | 76,967,800 | UNCHANGED | 0.00 |